Cargando…

Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System

Multiple sclerosis (MS) is characterized by peripheral and central inflammatory features, as well as demyelination and neurodegeneration. The available Food and Drug Administration (FDA)-approved drugs for MS have been designed to suppress the peripheral immune system. In addition, however, the effe...

Descripción completa

Detalles Bibliográficos
Autores principales: De Kleijn, Kim M. A., Martens, Gerard J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352301/
https://www.ncbi.nlm.nih.gov/pubmed/32545828
http://dx.doi.org/10.3390/ijms21124229